Philadelphia, Pennsylvania-- (Newsfile Corp. - January 10, 2025) - Kehoe Law Firm, P.C. is investigating potential securities class action claims on behalf of investors of TransMedics Group, Inc.

NDAQ:TMDX) Kehoe Law Firm, P.C. Securities Investigation on Behalf of Investors of TransMedics Group Stock Following Critical Report - NASDAQ: TMDX ...

Shares of TransMedics Group (NASDAQ: TMDX) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came ...

The report further alleges that TransMedics has been involved in kickbacks, billing fraud, unreported device failures, and ...

EST TransMedics (TMDX) down 10% to $65.39 after Scorpion Capital short reportStay Ahead of the Market:Discover outperforming stocks and ...

In diabetes care, the MiniMed 780G insulin pump system uses AI algorithms to predict and adjust insulin delivery based on ...

TransMedics Group Inc (TMDX) stock saw a decline, ending the day at $72.55 which represents a decrease of $-6.12 or -7.78% from the prior close of $78.67. The stock opened at $75.81 and touched a low ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

TransMedics is a commercial-stage medical technology company working on organ transplant therapy. Check out more about the ...

Detailed price information for Transmedics Group Inc (TMDX-Q) from The Globe and Mail including charting and trades.

Discover how TransMedics is revolutionizing organ transplants with cutting-edge technology and logistics, offering a ...

In recent trading, TransMedics Group Inc (TMDX) stock price has shown some volatility, fluctuating 10.37% over the last five trades and -3.29% over the past 30 trades. This represents a notable shift ...